Volume 20 No 8 (2022)
Download PDF
Cabergoline
Mohammed Rabie Osman Mahdy , AmgadOsman Gohar ,Hashem Fares Mohammed ,Alaa GamalAbd Al Azeem , Mohamed Ahmed Ahmed
Abstract
The syndrome nearly always presents either up to eight days once human chorionic gonadotrophin administration
in vulnerable patients (early onset) or throughout early physiological state, nine or additional days once human
chorionic gonadotrophin administration associated with physiological state evoked human chorionic gonadotrophin
production.
Keywords
Treating Modalities, Cavum and Lungs, Gonadotrophin Injection
Copyright
Copyright © Neuroquantology
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the Neuroquantology are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJECSE right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.